Metropolitan Life Insurance Company (MetLife)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,454
| Closed | -$22.9K | – | 2560 |
|
|
2023
Q1 | $22.9K | Sell |
5,454
-197
| -3% | -$1.02K | ﹤0.01% | 1817 |
|
|
2022
Q4 | $34K | Hold |
5,651
| – | – | ﹤0.01% | 1713 |
|
|
2022
Q3 | $32.9K | Hold |
5,651
| – | – | ﹤0.01% | 1738 |
|
|
2022
Q2 | $33.7K | Buy |
+5,651
| New | +$28.9K | ﹤0.01% | 1744 |
|
|
2018
Q3 | – | Sell |
-19,401
| Closed | -$96.6K | – | 2684 |
|
|
2018
Q2 | $96.6K | Buy |
+19,401
| New | +$84.9K | ﹤0.01% | 2338 |
|
|
2016
Q1 | – | Sell |
-12,287
| Closed | -$151K | – | 2605 |
|
|
2015
Q4 | $151K | Buy |
12,287
+1,868
| +18% | +$24.9K | ﹤0.01% | 2431 |
|
|
2015
Q3 | $152K | Buy |
10,419
+3,919
| +60% | +$67.7K | ﹤0.01% | 2466 |
|
|
2015
Q2 | $127K | Sell |
6,500
-4,642
| -42% | -$89.6K | ﹤0.01% | 2574 |
|
|
2015
Q1 | $202K | Buy |
11,142
+61
| +0.6% | +$1.37K | ﹤0.01% | 2048 |
|
|
2014
Q4 | $262K | Hold |
11,081
| – | – | ﹤0.01% | 2217 |
|
|
2014
Q3 | $268K | Buy |
11,081
+6,058
| +121% | +$157K | ﹤0.01% | 2172 |
|
|
2014
Q2 | $141K | Sell |
5,023
-4,726
| -48% | -$142K | ﹤0.01% | 2657 |
|
|
2014
Q1 | $331K | Sell |
9,749
-288
| -3% | -$9.84K | ﹤0.01% | 2085 |
|
|
2013
Q4 | $193K | Buy |
10,037
+563
| +6% | +$10.2K | ﹤0.01% | 2497 |
|
|
2013
Q3 | $155K | Buy |
+9,474
| New | +$110K | ﹤0.01% | 2604 |
|
